Company news
Bactiguard Holding Ab (OMXSTO:BACTI_B) news
Every Bactiguard Holding Ab press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Bulletin from Bactiguard Holding AB’s (publ) Annual General Meeting
May 19, 2026
Bactiguard, BD Strengthen Global Partnership
May 11, 2026
BACTI_B: Profitability maintained despite lower revenues, with strategic partnerships driving future growth
April 23, 2026
Notice to attend the Annual General Meeting of Bactiguard Holding AB
April 17, 2026
Bactiguard Holding AB’s Annual and Sustainability Report 2025
April 16, 2026
Invitation to presentation of Bactiguard’s interim report for the first quarter 2026
April 15, 2026
The Nomination Committee's proposal for Board of Directors to the 2026 Annual General Meeting
April 9, 2026
BACTI_B: Strong Q4 EBITDA and cost discipline offset revenue declines; partnerships and pipeline expanded
February 5, 2026
Bactiguard CEO Buys SEK 4.26 Mln Worth of Co Shares
October 30, 2025
BACTI_B: Profitability maintained in Q3 2025, with BD rebound and strong wound management growth
October 23, 2025
Bactiguard Holding AB: Quarterly Trading Report 2025 Q3
October 3, 2025
BACTI_B: License-driven growth and infection-prevention tech set the stage for ambitious 2030 targets
August 31, 2025
BACTI_B: EBITDA remained positive as revenues dipped, with strong growth in wound management and new cardiology initiatives
July 15, 2025
BACTI_B: Infection prevention technology and strong financial growth underpin ambitious 2030 targets
May 8, 2025
BACTI_B: Q1 2025 saw sustained profitability, revenue growth, and robust Wound Management performance
April 24, 2025
BACTI_B: Infection prevention technology and MedTech partnerships drive growth and ambitious 2030 targets
March 12, 2025
BACTI_B: Aims for SEK 600m revenue and SEK 200m EBITDA by 2030 through license-driven growth
March 6, 2025
BACTI_B: Strong revenue growth and profitability turnaround driven by licensing, despite orthopedic setback
February 6, 2025
BACTI_B: License-driven growth and proven infection prevention technology fuel strong financial momentum
January 8, 2025
BACTI_B: Advanced infection-prevention technology and global partnerships fuel robust sales growth
November 19, 2024
BACTI_B: Achieved Q3 EBITDA profitability and strong revenue growth, driven by BD partnership
October 24, 2024
BACTI_B: Innovative infection prevention technology and global partnerships support growth and profitability
September 19, 2024
BACTI_B: Stabilized license revenues and EBITDA, cost savings, and new leadership drove Q2 improvement
July 16, 2024
BACTI_B: Proven infection prevention technology and strategic partnerships target a $80bn global market
June 5, 2024